This Research Program is focused on defining the molecular basis of common human disorders. Studies are being undertaken to identify molecules that are involved in disease susceptibility, progression and prognosis with a focus on developing diagnostics and new therapeutics for human genetic disorders and infections. Therapeutic studies currently involve anti-cancer vaccine and personalised treatment options.
In the current era of personalised medicine, pharmaceutical and biotech companies are utlising genetic and other patient data to develop more effective and safer treatments targett to the specific disease or disorder. By combining molecular information with clinical outcomes, scientists and researchers minimise the risk and maximise the benefit of prescription medicines.